<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
----------------------------------
Washington, D.C. 20549
----------------------
SCHEDULE 13D
--------------
(Rule 13d-101)
Under the Securities Exchange Act of 1934
-----------------------------------------
DIMON INCORPORATED
------------------
(Name of Issuer)
Common Stock, No Par Value Per Share
------------------------------------
(Title of Class of Securities)
254394 10 9
--------------
(CUSIP Number)
Folium Inc.
c/o Maitland & Co.
35 Rue la Boetie
Paris, France 75008
011-33-1-538-91120
Attention: Steven Georgala
-------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
Copy to:
John D. Capers, Jr.
King & Spalding
191 Peachtree Street, N.E.
Atlanta, Georgia 30303
April 1, 1997
-----------------------------
(Date of Event Which Requires
Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition which is the subject of this Schedule 13D, and is
filing this schedule because of Rule 13d-1(b)(3) or (4), check the
following box: [ ]
(Continued on following pages)
1 of 5
<PAGE> 2
SCHEDULE 13D FORMS 7060
<TABLE>
<S> <C> <C>
- --------------------------------------------------------------------------------
CUSIP No. 254394 10 9 13D Page 2 of 5 Pages
--- ---
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSONS
Folium Inc.
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
SC
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEM 2(d) or 2(e)
[ ]
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
British Virgin Islands
- --------------------------------------------------------------------------------
7 SOLE VOTING POWER 4,070,764
--------------------------------------------------------------
NUMBER OF
SHARES 8 SHARED VOTING POWER -0-
BENEFICIALLY
OWNED BY --------------------------------------------------------------
EACH
REPORTING 9 SOLE DISPOSITIVE POWER 4,070,764
PERSON WITH
--------------------------------------------------------------
10 SHARED DISPOSITIVE POWER -0-
--------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
4,070,764
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES*
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
8.6% (1)
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
CO
- --------------------------------------------------------------------------------
</TABLE>
- -------------------------
(1) Assumes a total of 47,380,010 shares outstanding which represents
44,135,658 shares outstanding as of April 1, 1997 and 3,244,352, that
may be issued upon conversion of the security referenced in Item 5.
(Continued on following pages)
2 of 5
<PAGE> 3
STATEMENT PURSUANT TO RULE 13d-1
OF THE
GENERAL RULES AND REGULATIONS
UNDER THE
SECURITIES EXCHANGE ACT OF 1934
Item 1. Security and Issuer
The class of equity securities to which this Statement on Schedule 13D
relates is the Common Stock, no par value per share (the "Common Stock"), of
DIMON Incorporated (the "Issuer"), a Virginia corporation, with its principal
executive offices located at 512 Bridge Street, Danville, Virginia 24543-0681.
Item 2. Identity and Background
The name of the entity filing this Schedule 13D is Folium Inc., a
British Virgin Islands corporation. The primary business of Folium Inc. is
holding investments. Its business address is c/o Maitland & Co., 35 Rue la
Boetie, Paris, France 75008.
(d)-(e)
None of the entities or persons identified in this Item 2 has, during
the last five years, been convicted in a criminal proceeding (excluding traffic
violations or similar misdemeanors).
None of the entities or persons identified in this Item 2 has, during
the last five years, been a party to a civil proceeding of a judicial or
administrative body of competent jurisdiction and as a result of such
proceeding was or is subject to a judgment, decree or final order enjoining
future violations of, or prohibiting or mandating activities subject to,
Federal or State securities laws or finding any violation with respect to such
laws.
Item 3. Source and Amount of Funds or Other Consideration.
The shares were received as consideration for the shares of common
stock of Intabex Holdings Worldwide S.A. held by the Reporting Person and sold
to the Issuer.
(Continued on following pages)
3 of 5
<PAGE> 4
Item 4. Purpose of Transaction.
The Reporting Person acquired and continues to hold the Common Stock
reported herein for investment purposes. The Reporting Person has no plans or
proposals relating to any matters specified in paragraphs (a) through (j) of
Item 4 of Schedule 13D. However, the Reporting Person reserves the right to
adopt such plans or proposals in the future, subject to applicable regulatory
requirements.
Item 5. Interest in Securities of the Issuer.
(a) Folium Inc. may be deemed to be the beneficial owner (as that
term is defined in Rule 13d-3 under the Act) of 4,070,764 shares of Common
Stock, which constitutes 8.6% of the outstanding shares of the Common Stock.
Of those shares, 3,244,352 may be acquired by the Reporting
Person upon conversion of $93,340,000 principal amount of DIMON Incorporated
6.25% Convertible Subordinated Debentures at a price of $28.77 per share. The
Debentures are convertible immediately and thus are included in the amount of
Shares pursuant to Rule 13d-3(d)(1).
(b) Except as described in this Item 5(c), no transactions in the
shares of Common Stock have been effected by the Reporting Person during the
past 60 days. The Common Stock subject to this Schedule 13D was transferred to
Folium Inc. upon the closing of the sale of Intabex Holdings Worldwide S.A. to
the Issuer on April 1, 1997.
(c) No other person is known to have the right to receive or the
power to direct the receipt of dividends from, or the proceeds from the sale
of, the securities described above.
(d) Not applicable.
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect
to Securities of the Issuer.
There are no contracts, arrangements, understandings or relationships
with respect to the shares of the Common Stock owned by the Reporting Person.
Item 7. Material to be filed as Exhibits.
None.
(Continued on following pages)
4 of 5
<PAGE> 5
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: April 7, 1997
FOLIUM INC.
By: /s/ Steven Georgala
-----------------------
Name: Steven Georgala
----------------------
Title: Director
---------------------
5 of 5
